Sagent Pharmaceuticals Reports Second Quarter 2014 Financial Results
July 30, 2014 07:00 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., July 30, 2014 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced...
UPDATE: Sagent Pharmaceuticals Sets Date and Time for Release of Second Quarter 2014 Financial Results
July 17, 2014 18:12 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., July 17, 2014 (GLOBE NEWSWIRE) -- In a release issued earlier today by Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), the time of the teleconference and webcast was 9 a.m. ET. The...
Sagent Pharmaceuticals Sets Date and Time for Release of Second Quarter 2014 Financial Results
July 17, 2014 16:15 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., July 17, 2014 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced...
Sagent Pharmaceuticals Named to Crain's Chicago Business 2014 Fast Fifty List
June 09, 2014 08:00 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., June 9, 2014 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leading specialty pharmaceutical company with an emphasis on the injectable market, has been ranked...
Sagent Pharmaceuticals Reports First Quarter 2014 Financial Results
May 06, 2014 07:00 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., May 6, 2014 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with a specific emphasis on the injectable market, today...
Sagent Pharmaceuticals Sets Date and Time for Release of First Quarter 2014 Financial Results
April 23, 2014 08:00 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., April 23, 2014 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today...
Sagent Pharmaceuticals Announces the Reintroduction of Adenosine Injection, USP
April 21, 2014 08:00 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., April 21, 2014 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the reintroduction of Adenosine Injection, USP, an antiarrhythmic agent, now in improved...
Sagent Pharmaceuticals to Present at 13th Annual Needham Healthcare Conference
April 02, 2014 16:00 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., April 2, 2014 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced...
Sagent Pharmaceuticals and the Chicago Innovation Awards to Ring NASDAQ
March 31, 2014 08:00 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., March 31, 2014 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) will join the Chicago Innovation Awards, the Chicago region's foremost annual celebration of innovation,...
Sagent Pharmaceuticals Announces the Launch of Adenosine Injection, USP
March 31, 2014 08:00 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., March 31, 2014 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Adenosine Injection, USP, a pharmacologic stress agent, in two...